1992
DOI: 10.1038/ng0492-29
|View full text |Cite
|
Sign up to set email alerts
|

Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A

Abstract: Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited peripheral neuropathy in humans, characterized electrophysiologically by decreased nerve conduction velocities (NCVs). CMT1A is associated with a large submicroscopic DNA duplication in proximal 17p. In this report we demonstrate that a patient with a cytogenetically visible duplication, dup(17)(p11.2p12), has decreased NCV. Molecular analysis demonstrated this patient was duplicated for all the DNA markers duplicated in CMT1A as well as … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
136
0
3

Year Published

1993
1993
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 255 publications
(144 citation statements)
references
References 16 publications
5
136
0
3
Order By: Relevance
“…Similar to resistance, the cost reduction induced by the ID does not affect ace‐1 and most probably results from the partial restoration of gene‐dosage balance in coamplified loci (as the ~200 kb amplicon encompasses 10 other genes; Assogba et al., 2016). The increased gene dosage of the coamplified loci could indeed (i) alter biochemical equilibria between duplicated and nonduplicated interacting genes (Birchler & Veitia, 2007; Papp, Pal, & Hurst, 2003), (ii) overshoot optimal protein levels, thereby altering their function (Conrad & Antonarakis, 2007; Lupski et al., 1992), or (iii) increase the energy required for their production (Kalisky, Dekel, & Alon, 2007), all costs that may combine. Postduplication genomic rearrangements reducing the cost of gene‐dosage disturbance (such as the deletion studied here) are thus expected to be selected.…”
Section: Discussionmentioning
confidence: 99%
“…Similar to resistance, the cost reduction induced by the ID does not affect ace‐1 and most probably results from the partial restoration of gene‐dosage balance in coamplified loci (as the ~200 kb amplicon encompasses 10 other genes; Assogba et al., 2016). The increased gene dosage of the coamplified loci could indeed (i) alter biochemical equilibria between duplicated and nonduplicated interacting genes (Birchler & Veitia, 2007; Papp, Pal, & Hurst, 2003), (ii) overshoot optimal protein levels, thereby altering their function (Conrad & Antonarakis, 2007; Lupski et al., 1992), or (iii) increase the energy required for their production (Kalisky, Dekel, & Alon, 2007), all costs that may combine. Postduplication genomic rearrangements reducing the cost of gene‐dosage disturbance (such as the deletion studied here) are thus expected to be selected.…”
Section: Discussionmentioning
confidence: 99%
“…CNV can affect phenotypes and cause rare Mendelian disease traits such as Charcot-Marie-Tooth disease [136] and hereditary neuropathy [137]. It has also been shown to be associated with multiple complex diseases.…”
Section: Inheritance Of Copy Number Variationsmentioning
confidence: 99%
“…1 -4 It was shown in 1992 that the region duplicated in Charcot -Marie -Tooth (CMT) was flanked by highly similar (498%) sequences. 5 Unequal crossing over between these duplicons leads both to this duplication and the reciprocal deletion, which was later shown to cause hereditary neuropathy with liability to pressure palsies (HNPP). 6 Duplicons, also known as low copy repeats (LCRs), have since been implicated in many other disorders.…”
Section: Introductionmentioning
confidence: 99%